B lymphoblastic leukemia/lymphoma presenting as seventh cranial nerve palsy
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published August 21, 2013.
Article Versions
- Previous version (August 21, 2013 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Carlos Kamiya-Matsuoka, MD,
- Pedro Garciarena, MD,
- Hesham M. Amin, MD,
- Ivo W. Tremont-Lukats, MD and
- John F. de Groot, MD
- Carlos Kamiya-Matsuoka, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pedro Garciarena, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hesham M. Amin, MD,
NONE
NONE
NONE
Journal of Cellular and Molcular Medicine, Assistant Editor, 6 years
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ivo W. Tremont-Lukats, MD and
NONE
NONE
NONE
(1)Clinical Case Reports,Associate Editor, since March 2013.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- John F. de Groot, MD
1. Genentech (Advisory Board), 2. VBL Therapeutics (DSMB), 3. Deciphera Therapeutics (Advisory Board)
NONE
Merck, travel and speaker honoraria
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. AstraZeneca, 2. Sanofi-Aventis, 3. Adnexus, 4. EMD- Serono
NCI, PI, 20102012
NONE
ASCO Career Development Award
NONE
NONE
NONE
NONE
NONE
NONE
- Departments of Neuro-oncology (CK-M, PG, IWT-L, JFdG) and Hematopathology (HMA), The University of Texas MD Anderson Cancer Center, Houston; and the Department of Neurology (CK-M), The University of Texas Medical Branch, Galveston.
- Correspondence to:
ckmatsuo{at}utmb.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.